Start Publications Nanoproteomics enabling personalized nanomedicine
QSense

Nanoproteomics enabling personalized nanomedicine

Year: 2012

Journal: Advanced Drug Delivery Reviews Volume 64, Issue 13, October 2012, Pages 1522–1531, 20130117

Authors: Claudio Nicolini a b c, Nicola Bragazzi a d, Eugenia Pechkova a b

Last authors: Eugenia Pechkova

Organizations: a Nanobiotechnology and Biophysics Laboratories, Department Experimental Medicine, University of Genoa, Italy b Nanoworld Institute Fondazione EL.B.A Nicolini Bergamo, Italy c Biodesign Institute, Arizona State University, Tempe, USA d School of Public Health, Department of Health Sciences (DISSAL), University of Genoa, Italy

Country: USA, US, United States, United States of America, America, italy

Nucleic Acid Programmable Protein Arrays utilize a complex mammalian cell free expression system to produce proteins in situ. In alternative to fluorescent-labeled approaches a new label free method, emerging from the combined utilization of three independent and complementary nanotechnological approaches, appears capable to analyze protein function and protein–protein interaction in studies promising for personalized medicine. Quartz Micro Circuit nanogravimetry, based on frequency and dissipation factor, mass spectrometry and anodic porous alumina overcomes indeed the limits of correlated fluorescence detection plagued by the background still present after extensive washes. This could be further optimized by a homogeneous and well defined bacterial cell free expression system capable to realize the ambitious objective to quantify the regulatory protein networks in humans. Implications for personalized medicine of the above label free protein array using different test genes proteins are reported.